| 2021 |
Laurer E, Grünberger J, Naidoo U, Lanzersdorfer R, Wimleitner M, Tischlinger K, Högler W. Recombinant human parathyroid hormone (1–84) replacement therapy in a child with hypoparathyroidism. Bone. March 2021;144:115834. |
0 |
0 |
| 2021 |
Uday S, Shaw NJ, Mughal MZ, Randell T, Högler W, Santos R, Padidela R. Monitoring response to conventional treatment in children with XLH: value of ALP and rickets severity score (RSS) in a real world setting. Bone. October 2021;151:116025. |
0 |
0 |
| 2024 |
Farman MR, Rehder C, Malli T, Rockman-Greenberg C, Dahir K, Martos-Moreno GÁ, Linglart A, Ozono K, Seefried L, del Angel G, Webersinke G, Barbazza F, John LK, Delana Mudiyanselage SMA, Högler F, Nading EB, Huggins E, Rush ET, El-Gazzar A, Kishnani PS, Högler W. The Global ALPL gene variant classification project: dedicated to deciphering variants. Bone. January 1, 2024;178:116947. |
0 |
0 |
| 2021 |
Padidela R, Whyte MP, Glorieux FH, Munns CF, Ward LM, Nilsson O, Portale AA, Simmons JH, Namba N, Cheong HI, Pitukcheewanont P, Sochett E, Högler W, Muroya K, Tanaka H, Gottesman GS, Biggin A, Perwad F, Williams A, Nixon A, Sun W, Chen A, Skrinar A, Imel EA. Patient-reported outcomes from a randomized, active-controlled, open-label, phase 3 trial of burosumab versus conventional therapy in children with x-linked hypophosphatemia. Calcif Tiss Int. May 2021;108(5):622-633. |
0 |
0 |
| 2020 |
Högler W, Kapelari K. Oral iron for prevention and treatment of rickets and osteomalacia in autosomal dominant hypophosphatemia. J Bone Miner Res. February 2020;35(2):226-230. |
1 |
1 |
| 2020 |
Seefried L, Dahir K, Petryk A, Högler W, Linglart A, Martos‐Moreno GÁ, Ozono K, Fang S, Rockman‐Greenberg C, Kishnani PS. Burden of illness in adults with hypophosphatasia: data from the global hypophosphatasia patient registry. J Bone Miner Res. November 2020;35(11):2171-2178. |
5 |
2 |
| 2022 |
Reilly ML, Ain Nu, Muurinen M, Tata A, Huber C, Simon M, Ishaq T, Shaw N, Rusanen S, Pekkinen M, Högler W, Knapen MFCM, Born Mvd, Saunier S, Naz S, Cormier-Daire V, Benmerah A, Makitie O. Biallelic KIF24 variants are responsible for a spectrum of skeletal disorders ranging from lethal skeletal ciliopathy to severe acromesomelic dysplasia. J Bone Miner Res. September 2022;37(9):1642-1652. |
0 |
0 |
| 2023 |
Bergen DJM, Maurizi A, Formosa MM, McDonald GLK, El-Gazzar A, Hassan N, Brandi M-L, Riancho JA, Rivadeneira F, Ntzani E, Duncan EL, Gregson CL, Kiel DP, Zillikens MC, Sangiorgi L, Högler W, Duran I, Mäkitie O, Van Hul W, Hendrickx G. High bone mass disorders: new insights from connecting the clinic and the bench. J Bone Miner Res. February 2023;38(2):229-247. |
0 |
0 |